Abstract:
A self-configurable amplifier and method of amplification, including an RF signal level detector having an input connected to an RF signal, and an output configured to produce a control signal responsive to a power level of the RF signal. The control signal is supplied to a parametric adjustment circuit that includes an input connected to the control signal, and an output configured to provide a negative feedback responsive to the control signal. The negative feedback is supplied to an RF amplifier that includes an input forming an input of the self-configurable amplifier, an output forming an output of the self-configurable amplifier, and a control port connected to the output of the parametric adjustment circuit, such that one or more parameters of the RF amplifier is responsive to the negative feedback.
Abstract:
Techniques are described that can be used to reduce interference in a desired channel by one or more other channels. A radio includes a level detect logic that is responsive to both the frequency offset and amplitude of undesired signals and sets the gain applied to received signals based on the offset frequency and determined amplitude of undesired signals. For example, detection of a signal amplitude in an interfering signal in a channel adjacent to the desired channel may be made. Detection of a signal amplitude in an interfering signal in a channel other than the adjacent channel and desired channel may also be made. Based on detection of one or more interfering channel, a gain of an input signal may be adjusted. Interference arising from at least spectral re-growth of noise and clipping noise may be reduced.
Abstract:
A self-configurable amplifier and method of amplification, including an RF signal level detector having an input connected to an RF signal, and an output configured to produce a control signal responsive to a power level of the RF signal. The control signal is supplied to a parametric adjustment circuit that includes an input connected to the control signal, and an output configured to provide a negative feedback responsive to the control signal. The negative feedback is supplied to an RF amplifier that includes an input forming an input of the self-configurable amplifier, an output forming an output of the self-configurable amplifier, and a control port connected to the output of the parametric adjustment circuit, such that one or more parameters of the RF amplifier is responsive to the negative feedback.
Abstract:
A self-configurable amplifier and method of amplification, including an RF signal level detector having an input connected to an RF signal, and an output configured to produce a control signal responsive to a power level of the RF signal. The control signal is supplied to a parametric adjustment circuit that includes an input connected to the control signal, and an output configured to provide a negative feedback responsive to the control signal. The negative feedback is supplied to an RF amplifier that includes an input forming an input of the self-configurable amplifier, an output forming an output of the self-configurable amplifier, and a control port connected to the output of the parametric adjustment circuit, such that one or more parameters of the RF amplifier is responsive to the negative feedback.
Abstract:
The invention provides a process for producing lamotrigine of formula (I) which process comprises subjecting a compound of formula (II), wherein R is CN or CONH2, in an organic solvent, to ultraviolet or visible radiation and, when R is CN, to heat.
Abstract:
Sensory feedback ("chaperoning") systems and methods for guiding users in virtual/augmented reality environments such as walk-around virtual reality environments are described. Exemplary implementations assist with preventing collisions with objects in the physical operating space in which the user acts, among other potential functions and/or uses.
Abstract:
A compound of formula (I), wherein R is a C1-6 straight or branched chain alkyl group, a C2-6alkenyl group, a C2-6alkynyl group, a C3-6cycloalkyl group or a C3-6cycloalkyl C1-6alkyl group, each optionally substituted by one to three groups independently selected from: -CN; -NO2; a group -COR wherein R is hydrogen, C1-6alkyl, -OR wherein R is hydrogen or C1-6alkyl, or NR R , wherein R and R are independently selected from hydrogen or C1-6alkyl; a group -S(O)mR , wherein m is 0, 1 or 2, R is hydrogen, C1-6 alkyl, hydroxy or NR R , wherein R and R are independently hydrogen or C1-6 alkyl; a group PO(OR )2, wherein R is hydrogen or C1-6 alkyl; a group NR R , wherein R and R are independently selected from hydrogen, C1-6 alkyl, -COR , wherein R is hydrogen or C1-6alkyl, or -S(O)m'R , wherein m' is 0, 1 or 2 and R is hydrogen or C1-6alkyl; halo; or a group -OR , wherein R is hydrogen, C1-6 alkyl optionally substituted by one to three halo atoms, C6-10 aryl or -COR wherein R is hydrogen or C1-6 alkyl; p is 2 or 3, q is 1 or 2 and n is 0 or 1 and all salts, esters, amides and physiologically acceptable prodrugs thereof; pharmaceutical uses and formulations therefor; and processes for their preparation are disclosed.
Abstract translation:式(I)化合物,其中R 1为C 1-6直链或支链烷基,C 2-6烯基,C 2-6炔基,C 3-6环烷基或C 3-6环烷基C 1-6烷基 各自任选被一至三个独立地选自:-CN的基团取代; NO 2; 基团-COR 2其中R 2是氢,C 1-6烷基,-OR 3,其中R 3是氢或C 1-6烷基或NR 4 R 5,其中R 4 >和R 5独立地选自氢或C 1-6烷基; 基团-S(O)m R 6,其中m为0,1或2,R 6为氢,C 1-6烷基,羟基或NR 7 R 8,其中R 7和 R 8独立地是氢或C 1-6烷基; 基团PO(OR 9)2,其中R 9是氢或C 1-6烷基; NR 10 R 11基团,其中R 10和R 11独立地选自氢,C 1-6烷基,-COR 12,其中R 12是氢或C 1-6烷基, 或-S(O)m'R 13,其中m'为0,1或2,R 13为氢或C 1-6烷基; 光环; 或基团-OR 14,其中R 14是氢,任选被一至三个卤素原子取代的C 1-6烷基,C 6-10芳基或-COR 15,其中R 15是氢或C1- 6烷基; p为2或3,q为1或2,n为0或1,所有的盐,酯,酰胺和其生理上可接受的前药; 药用及其制剂; 并公开了其制备方法。